Alzheimer's disease (AD) is the most common neurodegenerative disease among the
elderly with a progressive decline in cognitive function significantly affecting quality of life …

Global concern on the potential impact of dementia is mounting. There are emerging calls
for studies in older populations to investigate the potential benefits of combining cognitive …

Here we critically review studies that used electroencephalography (EEG) or event-related
potential (ERP) indices as a biomarker of Alzheimer's disease. In the first part we overview …

Background Mild cognitive impairment (MCI) is known as a transitional stage or phase
between normal aging and dementia. In addition, it is associated with an increased risk of …

With an increasing focus on biomarkers in dementia research, illustrating the role of
neuropsychological assessment in detecting mild cognitive impairment (MCI) and …

Background: The purpose of this study was to investigate the long-term efficacy of
transcranial direct current stimulation (tDCS) in the neurorehabilitation of Alzheimer's …

There are numerous neuropsychological tests for assessing executive functions in aging,
which vary according to the different domains assessed. OBJECTIVE: To present a …

Low birth rates and increasing life expectancy experienced by developed societies have
placed an unprecedented pressure on governments and the health system to deal …

Alzheimer's disease (AD) is the most common neurodegenerative cause of dementia and is
responsible for significant individual morbidity and mortality, and economic impact on the …

Ethnopharmacological relevance Bacopa monnieri has a long history in Ayurvedic medicine
for neurological and behavioral defects. To assess its efficacy in improving cognitive …